Literature DB >> 10349347

[An autopsy case of Degos' disease with ascending thoracic myelopathy].

F Sugai1, H Sumi, Y Hara, K Kajiyama, H Morino, H Fujimura.   

Abstract

Degos' disease is a rare multisystem vasculopathy of unknown etiology. We report a 44-year-old man who presented himself with gait and sensory disturbances mainly due to thoracic transverse myelopathy four years after the appearance of many characteristic umbilicated papules over the trunk and extremities. He did not complain of abdominal pain or discomfort. Laboratory, electrophysiological and imaging studies did not show any characteristic change, except for the increase of protein contents and cell counts in the cerebrospinal fluid. We tried methylprednisolone pulse-dose therapy (1,000 mg/day x 3 days) five times, but this patient's neurological condition worsened stepwise after it, although the appearance of new skin lesion was suppressed. Intravenous infusion of ozagrel sodium and cyclophosphamide (1,000 mg/day) were also ineffective, and this patient died of respiratory failure after showing oculomotor paresis and comatose state. Necropsy revealed Degos' disease-specific vasculopathy in the central nervous system and the gastrointestinal tract, where occlusions of small-sized arteries and veins due to the intimal thickening were evident. The tissue necrosis was macroscopically remarkable in the brainstem and the thoracic spinal cord. The efficacy of steroid therapy for this disease should be investigated more carefully.

Entities:  

Mesh:

Year:  1998        PMID: 10349347

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

Review 1.  A case of systemic malignant atrophic papulosis (Köhlmeier-Degos' disease).

Authors:  Evans R Fernández-Pérez; Erica Grabscheid; Noah S Scheinfeld
Journal:  J Natl Med Assoc       Date:  2005-03       Impact factor: 1.798

Review 2.  Subacute posttraumatic ascending myelopathy: a literature review.

Authors:  J Zhang; G Wang
Journal:  Spinal Cord       Date:  2016-12-20       Impact factor: 2.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.